AI智能总结
E v a l u a t i o n r e p o r t © World Health Organization 2025. All rights reserved.The content of this document is not final and the text may be subject to editorial revisions before publication. The content of this draft, however, will not undergo substantive changes. The documentmay not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted,in part or in whole, in any form or by any means without the permission of the World HealthOrganization Cover photo: National Immunization Days campaign in Somalia @WHO / Abdirahman Caaylawe Contents Contents................................................................................................................................................... iiiAcknowledgements.................................................................................................................................. ivAcronyms and abbreviations .................................................................................................................... vExecutive summary.................................................................................................................................. vi1Introduction ..................................................................................................................................... 12Evaluation design and methodology................................................................................................ 93Findings .......................................................................................................................................... 154Conclusions .................................................................................................................................... 725Recommendations ......................................................................................................................... 756References...................................................................................................................................... 85 L i s to f t a b l e s Table 1WHO budget categorization........................................................................................................... 4Table 2Planned, financed and utilized costs of WCO ................................................................................ 5Table 3Expected uses of the evaluation by the stakeholders.................................................................... 8Table 4Achieved sample size of primary data collection......................................................................... 10Table 5Evaluation criteria and questions................................................................................................. 12Table 6Evaluation limitations and impact on the evaluation findings..................................................... 13Table 7Evidence map - internal and external coherence ........................................................................ 30Table 8Summary of contribution analysis of WHO’s strategic priorities in Somalia ............................... 40Table 9Immunization coverage by antigen (2024) .................................................................................. 42Table 10Disease burden........................................................................................................................... 43Table 11Funding for the 2022–2023 biennium ....................................................................................... 58Table 12Funding mobilization by strategic priority ................................................................................. 59Table 13WCO risk and mitigation measures for future funding.............................................................. 65 L i s to f f i g u r e s Figure 1.Trend of financing from 2018–2019 to 2024–2025, by segment ................................................ 5Figure 2.The reconstructed theory of change ......................................................................................... 17Figure 4.Immunization coverage by year................................................................................................. 42Figure 5.OPV vaccination status by age group......................................................................................... 44Figure 6.Perceptions of the effectiveness of WHO’s work in reaching the most vulnerable.................. 56 Acknowledgements This report on the evaluation of the contribution of the World Health Organization (WHO) in Somaliawas developed by the KonTerra Group evaluation team, comprising Dr Ngozi Akwataghibe, EvaluationTeam Lead; Dr Ricardo Solé Arqués, Senior Evaluator; Mr Mowlid Yusuf, National Consultant;Ms Mélanie Romat, Evaluation Manager; and Ms Jane Burke, Evaluation Quality Assurance Manager.We acknowledge the contributions of Ms Belén Díaz, Director of Evaluation and OrganizationalLearning, in the quality review of the incept